Results 211 to 220 of about 11,522 (222)

Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints Series

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 2, April 2025.
ABSTRACT Background In patients receiving anti‐cancer treatment, cachexia results in poorer oncological outcomes. However, there is limited understanding and no systematic review of oncological endpoints in cancer cachexia (CC) trials. This review examines oncological endpoints in CC clinical trials.
Olav Dajani   +23 more
wiley   +1 more source

Central Venous Access Device Complications and Premature Removal in Patients With Haematological Malignancies: A Multi‐Site Cohort Study

open access: yeseJHaem, Volume 6, Issue 2, April 2025.
Abstract Background Patients with haematological malignancies require urgent and reliable venous access for the administration of systemic anticancer therapies (SACTs) commonly via central venous access devices (CVADs). Disease pathophysiology and side effects of SACTs increase the risk of complications during the dwell time and premature removal. CVAD
Kerrie Curtis   +3 more
wiley   +1 more source

Evaluation of Hyponatremia in Infants on Vasopressin Therapy. [PDF]

open access: yesJ Pediatr Pharmacol Ther
Hawkins C, Hemmann B, Hemmelgarn T.
europepmc   +1 more source

Midline vs Peripherally Inserted Central Catheter for Outpatient Parenteral Antimicrobial Therapy.

open access: yesJAMA Intern Med
Paje D   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy